It’s ironic on the day that Dexcom reports second quarter results word comes that yet another Dexcom wannabe secured more financing. Will this Belgian wannabe end up coming to market or will it more likely become just another waffle is anyone’s guess. It really doesn’t matter as when it comes to the CGM market it’s owned by two companies and two companies alone, Abbott and Dexcom.
Let’s get the numbers out of the way first,
Revenue grew 34% versus the same quarter of the prior year to $451.8 million
U.S. revenue growth of . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.